Q4 2022 Holdings
Filed 2023-02-13 | 48 holdings | $117.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $47.6M | 4,220,048 | 40.5% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $23.1M | 1,994,941 | 19.7% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $17.9M | 3,557,630 | 15.3% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $14.2M | 898,631 | 12.1% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $6.5M | 509,572 | 5.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $5.6M | 137,411 | 4.7% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.8M | 388,144 | 1.5% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $143.6K | 2,606,247 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $67.8K | 6,657,992 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $49.0K | 1,678,207 | 0.0% |
| Geron Corp(GERN) | Common | 374163103 | $46.7K | 19,282,834 | 0.0% |
| Impel NeuroPharma Inc | Common | 45258K109 | $43.3K | 2,884,789 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | Common | 92332V107 | $42.7K | 1,303,294 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $34.7K | 4,120,134 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $33.2K | 2,262,200 | 0.0% |
| Vaxcyte Inc(PCVX) | Common | 92243G108 | $27.8K | 579,508 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $25.0K | 1,681,199 | 0.0% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $22.9K | 872,151 | 0.0% |
| VectivBio Holding AG | Common | H9060V101 | $20.2K | 2,333,300 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $19.7K | 2,754,095 | 0.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $12.2K | 244,375 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $11.9K | 7,750,828 | 0.0% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $10.4K | 338,721 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $9.1K | 8,124,174 | 0.0% |
| Bellus Health Inc(BLU) | Common | 07987C204 | $8.4K | 1,017,152 | 0.0% |
| Instil Bio Inc | Common | 45783C101 | $7.9K | 12,486,787 | 0.0% |
| Vera Therapeutics Inc(VERA) | Common | 92337R101 | $7.8K | 400,666 | 0.0% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $6.9K | 3,015,545 | 0.0% |
| Merus NV | Common | N5749R100 | $6.8K | 438,590 | 0.0% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $6.7K | 577,642 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $5.8K | 856,008 | 0.0% |
| BioAtla Inc(BCAB) | Common | 09077B104 | $5.3K | 637,181 | 0.0% |
| Cincor Pharma Inc | Common | 17240Y109 | $5.2K | 421,635 | 0.0% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $5.0K | 3,871,291 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $4.2K | 655,057 | 0.0% |
| DBV Technologies SA | Sponsored ADR | 23306J101 | $4.1K | 2,708,875 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $4.1K | 1,689,515 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $3.6K | 4,249,918 | 0.0% |
| Aligos Therapeutics Inc | Common | 01626L105 | $3.4K | 3,547,030 | 0.0% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $2.3K | 1,856,011 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $2.2K | 961,358 | 0.0% |
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | $1.0K | 2,840,909 | 0.0% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $1.0K | 489,473 | 0.0% |
| Immunic Inc(IMUX) | Common | 4525EP101 | $833 | 632,184 | 0.0% |
| Minerva Surgical Inc | Common | 60343F106 | $495 | 2,215,667 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $466 | 370,068 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $167 | 140,255 | 0.0% |